Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global tramadol drug market 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Dosage form trends
2.1.4 Route of administration trends
2.1.5 Distribution channel trends
Chapter 3 Tramadol Drug Market Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of pain disorders
3.2.1.2 Rising number of surgical procedures
3.2.1.3 Increasing geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Associated side effects
3.2.2.2 Strict regulatory norms
3.3 Growth potential analysis
3.3.1 By dosage form
3.3.2 By route of administration
3.3.3 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard, 2022
Chapter 5 Tramadol Drug Market Size and Forecast, By Dosage Form, 2018 - 2032 (USD Million)
5.1 Key trends, by dosage form
5.2 Tablet
5.3 Capsule
5.4 Liquid
5.5 Suspension
5.6 Other dosage forms
Chapter 6 Tramadol Drug Market Size and Forecast, By Route of Administration, 2018 - 2032 (USD Million)
6.1 Key trends, by route of administration
6.2 Oral
6.3 Parenteral
6.4 Other routes of administration
Chapter 7 Tramadol Drug Market Size and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)
7.1 Key trends, by distribution channel
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy
Chapter 8 Tramadol Drug Market Size and Forecast, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Zydus Cadila
9.2 Purdue Pharma
9.3 Mankind Pharma Ltd
9.4 Mundipharma
9.5 Amneal Pharmaceuticals
9.6 Par Pharmaceuticals
9.7 Vertical Pharmaceuticals
9.8 Grunenthal Group
9.9 Nippon Shinyaku Co., Ltd
